Bio-Rad Laboratories (BIO-B) Change in Account Payables (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Change in Account Payables data on file, last reported at $515.8 million in Q1 2026.

• Change in Account Payables for Q1 2026 came in at $515.8 million, up 5.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 5.08% YoY), and the FY2025 annual result was $2.1 billion, changed 0.03% from the prior year.
• Change in Account Payables eased to $515.8 million in Q1 2026 per BIO-B's latest filing, from $547.5 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $620.3 million in Q2 2023 and troughed at $446.4 million in Q3 2024.
• A 5-year average of $546.0 million and a median of $547.5 million in 2025 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables soared 30.05% in 2022, then slipped 18.67% in 2024.
• A 5-year view of Change in Account Payables shows it stood at $607.5 million in 2022, then slipped by 14.68% to $518.3 million in 2023, then grew by 1.65% to $526.9 million in 2024, then rose by 3.91% to $547.5 million in 2025, then slipped by 5.79% to $515.8 million in 2026.
• Business Quant data shows BIO-B's Change in Account Payables at $515.8 million in Q1 2026, $547.5 million in Q4 2025, and $517.5 million in Q3 2025.